ABOUT BOYDS
Navigators of Uncertainty.
A global drug development consultancy helping biotech, pharma and medical device companies bring innovative therapies to patients faster.
The expertise to
turn possibility
into progress.
Boyds is a dynamic and rapidly growing global drug development consultancy focused on providing specialist consultancy services to an international client base, supporting the development of new, cutting-edge medicines for patient benefit.
Years supporting global drug development
Clients supported across the globe
Cell & gene therapies approved with Boyds’ support
Client satisfaction rate
A consultancy built
for what's next.
Founded in 2005 by Professor Alan Boyd, Boyds has been navigating uncertainty from day one. We started by helping life sciences companies and academic groups turn promising science into medicines, and continue to work at the forefront of drug development today.
We support novel and emerging technologies across a broad range of areas, from rare diseases, cell and gene therapies, small molecules, biologics and orphan drugs to women’s health — often in areas where there is no established precedent and no simple path forward.
EXPLORE BOYDS
People, expertise and a shared purpose.
Navigate what comes next.
When the path through drug development is complex, Boyds brings the expertise, judgment and clarity to help you move forward.